THE CONSIDERATION FOR AND THE
TERMS OF THE AGREEMENT AND IS SIGNING THIS AGREEMENT KNOWINGLY AND VOLUNTARILY
OF HIS OWN FREE WILL, AFTER A FULL OPPORTUNITY TO REVIEW ITS TERMS;
(B)
HE IS NOT ENTITLED TO THE BENEFITS IN SECTION 3(B) AND SECTION 3(C)
UNLESS HE AGREES TO AND HONORS THE TERMS OF THIS AGREEMENT; AND
(C)
HE UNDERSTANDS THAT, SUBJECT TO THE LIMITATIONS CONTAINED HEREIN,
THE AGREEMENT INCLUDES A GENERAL RELEASE OF ANY AND ALL KNOWN AND UNKNOWN,
FORESEEN AND UNFORESEEN CLAIMS THROUGH THE DATE OF HIS SIGNING OF THIS AGREEMENT
THAT HE MAY HAVE AGAINST THE COMPANY.
4
IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date
set forth below.
REXAHN PHARMACEUTICALS, INC.
By:
/s/ Douglas J. Swirsky
Name:
Douglas J. Swirsky
Title:
President and Chief Executive Officer
Date:
11/16/18
Peter Suzdak, Ph.D.
/s/ Peter Suzdak
Date:
11/16/18
5